Imperial NIHR Biomedical Research Centre

Translating research into patient benefits

Imperial Healthcare Trust Logo Imperical College Logo National Institute for Health Research
Research excellence within the BRC
Driving patient benefit through research
How and why to get involved in our research
Working in partnership to deliver research excellence
Who we are and what we do

About us

Hammersmith Hospital

The Imperial NIHR Biomedical Research Centre (BRC) undertakes translational research, which means taking the findings from basic research more quickly and efficiently into medical practice and, thus, improving health outcomes for our patients.

Latest NIHR Funding announcement

April 1st, 2012 marks the beginning of the new Imperial NIHR BRC award. In August 2011, NIHR pledged £112M in funding to the Imperial NIHR Biomedical Research Centre to be used to facilitate the continued development of cutting-edge translational research and healthcare innovations within Imperial NIHR BRC over the course of the next five years.

Read more

Wellcome Trust-McMichael Clinical Research Facility awarded NIHR Funding

On March 1st 2012, it was announced that the Wellcome Trust-McMichael Clinical Research Facility has been awarded £10.9M in funding from the NIHR, with effect from 1st September 2012. This NIHR investment is to support the translation of scientific advances into benefits for patients through purpose-built Clinical Research Facilities (CRFs).

Read more

Therapeutic Primer Fund 2012

Imperial NIHR BRC in partnership with Imperial Innovations sought applications from researchers within Imperial Academic Health Science Centre (AHSC) for funding of projects that support the early stages of drug/therapeutic discovery.

Read more

Industry partners

A key part of our vision is to translate biomedical research into practice. For much of this translation we work in partnership. Researchers are supported to translate their ideas and discoveries into new products or treatments through Imperial Innovations.

Read more

Low iron levels in the blood may indicate blood clot risk

The BRC-supported study, led by Dr Claire Shovlin and published in Thorax used carefully timed blood samples in patients with the inherited blood vessel disease hereditary haemorrhagic telangiectasia (HHT) to identify a link between low iron levels and potentially lethal blood clots. These findings may lead to changes in routine venous thromboembolism (VTE) risk assessment and prevention strategies.

Read more

Case studies

A sample of the many ways which we have delivered results.